Sentiment-Signal
32,0
Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
61.3
13D-Filing vorhanden
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 03.12.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 29.08.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | nt No. 1 to the Current Report on Form 8-K amends Item 5.02(c) of the Current Report on Form 8-K filed by Strata Critica |
| 04.08.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | th the Securities and Exchange Commission. Item 5.02 Departure of Directors or Certain Officers; Election of Directors |
| 30.03.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 1 and is incorporated herein by reference. Item 5.02 Departure of Directors or Certain Officers; Election of Directors |
Stammdaten
Strata Critical Medical, Inc. provides time critical logistics solutions and specialized medical services to healthcare providers across the United States. The company operates as both an air and ground transporter of human organs for transplant. The company was formerly known as Blade Air Mobility, Inc. and change its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.
Unternehmen & Branche
| Name | Strata Critical Medical, Inc. |
|---|---|
| Ticker | SRTA |
| CIK | 0001779128 |
| Boerse | US |
| Sektor | Industrials |
| Industrie | Airlines, Airports & Air Services |
| SIC | 8000 · Services-Health Services |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 424,9 Mio. USD |
| Beta | 2,11 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 197,141,000 | 41,347,000 | 0.50 | 325,472,000 | 279,072,000 |
| 2025-09-30 | 10-Q | 49,298,000 | 57,416,000 | 0.70 | 335,078,000 | 283,000,000 |
| 2025-06-30 | 10-Q | 70,801,000 | -3,743,000 | -0.05 | 257,919,000 | 223,100,000 |
| 2025-03-31 | 10-Q | 54,306,000 | -3,493,000 | -0.04 | 250,550,000 | 219,732,000 |
| 2024-12-31 | 10-K | 146,817,000 | -27,307,000 | -0.35 | 256,675,000 | 221,938,000 |
| 2024-09-30 | 10-Q | 36,062,000 | -1,954,000 | -0.03 | 282,945,000 | 233,499,000 |
| 2024-06-30 | 10-Q | 67,945,000 | -11,326,000 | -0.15 | 280,331,000 | 229,386,000 |
| 2024-03-31 | 10-Q | 51,514,000 | -4,234,000 | -0.06 | 282,792,000 | 236,609,000 |
| 2023-12-31 | 10-K | 225,180,000 | -56,076,000 | -0.76 | 294,938,000 | 234,300,000 |
| 2023-09-30 | 10-Q | 71,442,000 | 289,000 | 0.00 | 317,514,000 | 262,877,000 |
| 2023-06-30 | 10-Q | 60,989,000 | -12,232,000 | -0.17 | 320,183,000 | 260,764,000 |
| 2023-03-31 | 10-Q | 45,271,000 | -10,192,000 | -0.14 | 322,432,000 | 270,201,000 |
| 2022-12-31 | 10-K | 146,120,000 | -27,260,000 | -0.38 | 325,025,000 | 274,489,000 |
| 2022-09-30 | 10-Q | 45,722,000 | -9,245,000 | -0.13 | 326,657,000 | 282,705,000 |
| 2022-06-30 | 10-Q | 35,633,000 | 8,412,000 | 0.10 | 324,187,000 | 292,291,000 |
| 2022-03-31 | 10-Q | 26,630,000 | -11,012,000 | -0.16 | 326,627,000 | 281,470,000 |
| 2021-12-31 | 10-K | 24,618,000 | 772,000 | 0.01 | 335,884,000 | 291,371,000 |
| 2021-09-30 | 10-Q | 20,316,000 | -9,184,000 | -0.13 | 291,229,000 | |
| 2021-09-30 | 10-K | 50,526,000 | -40,052,000 | -0.93 | 343,394,000 | 291,229,000 |
| 2021-06-30 | 10-Q | 12,951,000 | -24,286,000 | -0.47 | 346,149,000 | 296,698,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2025-12-09 | Heyburn William A. | Director, Officer, Co-CEO and CFO | Open Market Purchase | 17,000 | 4.47 | 76,044.40 | +41,2% | |
| 2025-12-05 | LAUCK ANDREW | Director | Open Market Purchase | 5,000 | 4.37 | 21,825.00 | +11,8% | |
| 2025-11-20 | Love Reginald | Director | Open Market Sale | -11,000 | 4.37 | -48,070.00 | -26,0% | |
| 2025-11-19 | Love Reginald | Director | Open Market Sale | -11,000 | 4.31 | -47,434.20 | -25,7% | |
| 2025-08-04 | Heyburn William A. | Officer, Chief Financial Officer | Open Market Sale | -46,918 | 4.94 | -231,821.84 | -125,6% | |
| 2025-08-04 | Tomkiel Melissa M. | Officer, President and General Counsel | Open Market Sale | -47,995 | 4.94 | -237,133.70 | -128,5% | |
| 2025-06-09 | Tomkiel Melissa M. | Officer, President and General Counsel | Open Market Sale | -100,000 | 4.08 | -407,530.00 | -220,8% | |
| 2025-06-09 | Heyburn William A. | Officer, Chief Financial Officer | Open Market Sale | -100,000 | 4.07 | -406,590.00 | -220,3% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.